These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16487618)

  • 1. Clinical characteristics and prognostic markers in disulfiram-induced liver injury.
    Björnsson E; Nordlinder H; Olsson R
    J Hepatol; 2006 Apr; 44(4):791-7. PubMed ID: 16487618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation for disulfiram-induced hepatic failure.
    Rabkin JM; Corless CL; Orloff SL; Benner KG; Flora KD; Rosen HR; Olyaei AJ
    Am J Gastroenterol; 1998 May; 93(5):830-1. PubMed ID: 9625138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden.
    Björnsson E; Jerlstad P; Bergqvist A; Olsson R
    Scand J Gastroenterol; 2005 Sep; 40(9):1095-101. PubMed ID: 16165719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and prognostic markers in severe drug-induced liver disease.
    Björnsson E; Olsson R
    Hepatology; 2005 Aug; 42(2):481-9. PubMed ID: 16025496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse hepatic reactions associated with calcium carbimide and disulfiram therapy: is there still a role for these drugs?
    Verge C; Lucena MI; López-Torres E; Puche-Garcia MJ; Fraga E; Romero-Gomez M; Andrade RJ
    World J Gastroenterol; 2006 Aug; 12(31):5078-80. PubMed ID: 16937512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In the zone between drug insurance and patient insurance. A case of liver damage, requiring transplantation, caused by antabuse].
    Schmidt D
    Lakartidningen; 1996 Sep; 93(38):3262, 3265. PubMed ID: 8926792
    [No Abstract]   [Full Text] [Related]  

  • 7. [A severe liver damage caused by disulfiram treatment].
    Vuorinen K; Mäkinen J; Haapamäki J; Pohjola-Sintonen S
    Duodecim; 1998; 114(4):357-61. PubMed ID: 11466948
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-induced liver injury: a cohort study on patients referred to the Danish transplant center over a five year period.
    Baekdal M; Ytting H; Skalshøi Kjær M
    Scand J Gastroenterol; 2017 Apr; 52(4):450-454. PubMed ID: 27973926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation for disulfiram-induced fulminant hepatic failure.
    Mohanty SR; LaBrecque DR; Mitros FA; Layden TJ
    J Clin Gastroenterol; 2004 Mar; 38(3):292-5. PubMed ID: 15128079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disulfiram hepatotoxicity: case report.
    Black JL; Richardson JW
    J Clin Psychiatry; 1985 Feb; 46(2):67-8. PubMed ID: 3968049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cyanamide and disulfiram in effects on liver function.
    Tamai H; Yokoyama A; Okuyama K; Takahashi H; Maruyama K; Suzuki Y; Ishii H
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):97S-99S. PubMed ID: 10803789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of autoantibodies to specific cytochromes P450 in a case of disulfiram hepatitis.
    Eliasson E; Stål P; Oksanen A; Lytton S
    J Hepatol; 1998 Nov; 29(5):819-25. PubMed ID: 9833921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Severe toxic hepatitis.
    Pinillos H; Holt PR; Thung S
    Dig Dis Sci; 2007 Sep; 52(9):2460-1. PubMed ID: 17415657
    [No Abstract]   [Full Text] [Related]  

  • 14. [Liver damage attributed to the use of disulfiram].
    Kerkhof SC; de Doelder PF; Harinck HI; Stricker BH
    Ned Tijdschr Geneeskd; 1995 Nov; 139(46):2378-81. PubMed ID: 7501079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfiram hepatitis.
    Morris SJ; Kanner R; Chiprut RO; Schiff ER
    Gastroenterology; 1978 Jul; 75(1):100-2. PubMed ID: 401083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fulminant hepatitis caused by disulfiram].
    Zala G; Schmid M; Bühler H
    Dtsch Med Wochenschr; 1993 Sep; 118(38):1355-60. PubMed ID: 8404476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfiram therapy--adverse drug reactions and interactions.
    Enghusen Poulsen H; Loft S; Andersen JR; Andersen M
    Acta Psychiatr Scand Suppl; 1992; 369():59-65; discussion 65-6. PubMed ID: 1471554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal fulminant hepatic failure related to the use of disulfiram.
    Watts TE; Pandey RA; Vancil TJ
    J Ark Med Soc; 2014 Jun; 110(13):280-3. PubMed ID: 25004669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fulminant hepatitis induced by disulfiram in a patient with alcoholic cirrhosis. Survival after liver transplantation].
    Vanjak D; Samuel D; Gosset F; Derrida S; Moreau R; Soupison T; Soulier A; Bismuth H; Sicot C
    Gastroenterol Clin Biol; 1989 Dec; 13(12):1075-8. PubMed ID: 2625187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfiram-induced fulminating hepatitis: guidelines for liver-panel monitoring.
    Wright C; Vafier JA; Lake CR
    J Clin Psychiatry; 1988 Nov; 49(11):430-4. PubMed ID: 3053669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.